Art

J-GLOBAL ID：201702282494592045   Reference number：17A1688638

Cystatin C-Adiponectin Complex in Plasma Associates with Coronary Plaque Instability

シスタチンC-冠動脈プラークの不安定性と血漿中のアディポネクチン複合体との関連

Author (7)： Matsumoto Akane (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Yamamoto Hiroyasu (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Matsuoka Tetsuro (Department of Cardiology, Hyogo Prefectural Nishinomiya Hospital) ,  Kayama Kento (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Onishi Sumire (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Matsuo Natsumi (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine) ,  Kihara Shinji (Department of Biomedical Informatics, Division of Health Sciences, Osaka University Graduate School of Medicine)
Material： Journal of Atherosclerosis and Thrombosis (Web)  (J Atheroscler Thromb (Web))
Volume： 24  Issue： 9  Page： 970-979(J-STAGE)  Publication year： 2017 
JST Material Number： U0153A  ISSN： 1880-3873  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： Cystatin C ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1688638&from=J-GLOBAL&jstjournalNo=U0153A") }}

Author keywords (5)： Adiponectin ,  Cystatin C ,  Atherosclerosis ,  Plaque ,  Coronary artery disease

JST classification (1)： Cardiovascular system diseases  (GJ03000C)

Reference (44)：

• 1) WHO: Global status report on noncommunicable diseases 2014
• 2) Group UPDSU: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998; 352: 837-853
• 3) He J and Whelton PK: Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am Heart J, 1999; 138: 211-219
• 4) Saito Y, Shirai K, Sasaki N, Shinomiya M and Yoshida S: Prognosis of hypercholesterolemic patients taking pravastatin for five years: the Chiba Lipid Intervention Program (CLIP) Study. J Atheroscler Thromb, 2002; 9: 99-108
• 5) Virmani R, Kolodgie FD, Burke AP, Farb A and Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol, 2000; 20: 1262-1275

Terms in the title (6)： シスタチンC ,  冠動脈プラーク ,  不安定性 ,  血漿 ,  アディポネクチン ,  複合体